Ashwagandha continues to face regulatory scrutiny in Europe, highlighting the need for high-quality safety data generated using internationally recognised standards. A recent OECD- and GLP-compliant safety assessment of a fully characterised root-and-leaf ashwagandha extract demonstrated no genotoxicity, no treatment-related adverse effects in a 90-day study, normal liver findings and no adverse endocrine effects, even at…
Contributor
R&D Scientist at Kerry
Go To Contributor's Articles
Niall Gillen is a biotechnology graduate with a focus on the analytical and biological sciences underpinning ingredient quality and authentication.
His interests sit at the intersection of science and industry, exploring how research can inform commercial decisions in the functional nutrition and botanicals space.
Niall is committed to translating complex scientific concepts into accessible insights for the food and wellness sectors.
A Rise in Botanical Supplements Walking into a supermarket today or shopping online, it is hard to miss the shift in the types of products for sale such as matcha coffees, lion’s mane teas, ginseng soft drinks and ashwagandha gummies. All these products stem from the meteoric rise of functionalism in our foods and beverages….



